nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLCO3A1—Methotrexate—bone cancer	0.172	0.214	CbGbCtD
Dinoprostone—ABCC5—Cisplatin—bone cancer	0.17	0.211	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—bone cancer	0.11	0.137	CbGbCtD
Dinoprostone—SLC22A2—Cisplatin—bone cancer	0.0594	0.0737	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—bone cancer	0.0568	0.0706	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—bone cancer	0.0542	0.0672	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—bone cancer	0.0529	0.0657	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—bone cancer	0.038	0.0471	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—bone cancer	0.0358	0.0445	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—bone cancer	0.0331	0.0411	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—bone cancer	0.023	0.0286	CbGbCtD
Dinoprostone—Oedema genital—Epirubicin—bone cancer	0.00331	0.0616	CcSEcCtD
Dinoprostone—Oedema genital—Doxorubicin—bone cancer	0.00306	0.057	CcSEcCtD
Dinoprostone—Neck stiffness—Methotrexate—bone cancer	0.001	0.0187	CcSEcCtD
Dinoprostone—Nuchal rigidity—Methotrexate—bone cancer	0.000922	0.0172	CcSEcCtD
Dinoprostone—Hearing impaired—Cisplatin—bone cancer	0.000915	0.017	CcSEcCtD
Dinoprostone—Pain—Carboplatin—bone cancer	0.000906	0.0169	CcSEcCtD
Dinoprostone—Hiccups—Cisplatin—bone cancer	0.000871	0.0162	CcSEcCtD
Dinoprostone—Wheezing—Cisplatin—bone cancer	0.000846	0.0158	CcSEcCtD
Dinoprostone—Body temperature increased—Carboplatin—bone cancer	0.000838	0.0156	CcSEcCtD
Dinoprostone—Deafness—Cisplatin—bone cancer	0.000707	0.0132	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Cisplatin—bone cancer	0.000653	0.0122	CcSEcCtD
Dinoprostone—Laryngitis—Epirubicin—bone cancer	0.000621	0.0116	CcSEcCtD
Dinoprostone—Dehydration—Cisplatin—bone cancer	0.000588	0.011	CcSEcCtD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—bone cancer	0.000578	1	CrCbGaD
Dinoprostone—Laryngitis—Doxorubicin—bone cancer	0.000574	0.0107	CcSEcCtD
Dinoprostone—Cramp muscle—Cisplatin—bone cancer	0.000569	0.0106	CcSEcCtD
Dinoprostone—Musculoskeletal stiffness—Methotrexate—bone cancer	0.000533	0.00992	CcSEcCtD
Dinoprostone—Sweating increased—Cisplatin—bone cancer	0.000532	0.00991	CcSEcCtD
Dinoprostone—Skin discolouration—Methotrexate—bone cancer	0.000529	0.00986	CcSEcCtD
Dinoprostone—Skin discolouration—Epirubicin—bone cancer	0.000495	0.00922	CcSEcCtD
Dinoprostone—Inflammation—Methotrexate—bone cancer	0.000493	0.00918	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Cisplatin—bone cancer	0.00048	0.00895	CcSEcCtD
Dinoprostone—Vaginal inflammation—Methotrexate—bone cancer	0.000478	0.0089	CcSEcCtD
Dinoprostone—Myocardial infarction—Cisplatin—bone cancer	0.000478	0.0089	CcSEcCtD
Dinoprostone—Inflammation—Epirubicin—bone cancer	0.000461	0.00859	CcSEcCtD
Dinoprostone—Skin discolouration—Doxorubicin—bone cancer	0.000458	0.00853	CcSEcCtD
Dinoprostone—Vaginal infection—Methotrexate—bone cancer	0.000451	0.0084	CcSEcCtD
Dinoprostone—Vaginal inflammation—Epirubicin—bone cancer	0.000447	0.00833	CcSEcCtD
Dinoprostone—Hiccups—Epirubicin—bone cancer	0.000447	0.00833	CcSEcCtD
Dinoprostone—Inflammation—Doxorubicin—bone cancer	0.000427	0.00795	CcSEcCtD
Dinoprostone—Vaginal infection—Epirubicin—bone cancer	0.000422	0.00787	CcSEcCtD
Dinoprostone—Vaginal inflammation—Doxorubicin—bone cancer	0.000414	0.00771	CcSEcCtD
Dinoprostone—Hiccups—Doxorubicin—bone cancer	0.000414	0.00771	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Epirubicin—bone cancer	0.000411	0.00765	CcSEcCtD
Dinoprostone—Flushing—Cisplatin—bone cancer	0.000406	0.00756	CcSEcCtD
Dinoprostone—Immune system disorder—Cisplatin—bone cancer	0.000395	0.00736	CcSEcCtD
Dinoprostone—Hypertonia—Epirubicin—bone cancer	0.000392	0.0073	CcSEcCtD
Dinoprostone—Arrhythmia—Cisplatin—bone cancer	0.000391	0.00728	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—bone cancer	0.000391	0.00728	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Doxorubicin—bone cancer	0.00038	0.00708	CcSEcCtD
Dinoprostone—Muscle spasms—Cisplatin—bone cancer	0.000366	0.00682	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—bone cancer	0.000363	0.00676	CcSEcCtD
Dinoprostone—Eye pain—Epirubicin—bone cancer	0.00036	0.0067	CcSEcCtD
Dinoprostone—Vision blurred—Cisplatin—bone cancer	0.000359	0.00668	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000359	0.00668	CcSEcCtD
Dinoprostone—Tremor—Cisplatin—bone cancer	0.000357	0.00664	CcSEcCtD
Dinoprostone—Hot flush—Epirubicin—bone cancer	0.000347	0.00646	CcSEcCtD
Dinoprostone—Menopausal symptoms—Epirubicin—bone cancer	0.000344	0.00641	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000336	0.00625	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—bone cancer	0.000333	0.0062	CcSEcCtD
Dinoprostone—Myalgia—Cisplatin—bone cancer	0.000324	0.00604	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—bone cancer	0.000321	0.00598	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—bone cancer	0.000318	0.00593	CcSEcCtD
Dinoprostone—Anaphylactic shock—Cisplatin—bone cancer	0.000311	0.00579	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00031	0.00578	CcSEcCtD
Dinoprostone—Cardiac arrest—Epirubicin—bone cancer	0.000309	0.00575	CcSEcCtD
Dinoprostone—Tachycardia—Cisplatin—bone cancer	0.000303	0.00565	CcSEcCtD
Dinoprostone—Dehydration—Epirubicin—bone cancer	0.000302	0.00562	CcSEcCtD
Dinoprostone—Hyperhidrosis—Cisplatin—bone cancer	0.0003	0.0056	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—bone cancer	0.0003	0.00559	CcSEcCtD
Dinoprostone—Hypotension—Cisplatin—bone cancer	0.00029	0.00541	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—bone cancer	0.000286	0.00532	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000283	0.00527	CcSEcCtD
Dinoprostone—Asthma—Epirubicin—bone cancer	0.000281	0.00523	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—bone cancer	0.000279	0.0052	CcSEcCtD
Dinoprostone—Paraesthesia—Cisplatin—bone cancer	0.000279	0.0052	CcSEcCtD
Dinoprostone—Dyspnoea—Cisplatin—bone cancer	0.000277	0.00516	CcSEcCtD
Dinoprostone—Pain—Cisplatin—bone cancer	0.000266	0.00495	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—bone cancer	0.00026	0.00484	CcSEcCtD
Dinoprostone—Body temperature increased—Cisplatin—bone cancer	0.000246	0.00458	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—bone cancer	0.000238	0.00444	CcSEcCtD
Dinoprostone—Hypersensitivity—Cisplatin—bone cancer	0.000229	0.00426	CcSEcCtD
Dinoprostone—Asthenia—Cisplatin—bone cancer	0.000223	0.00415	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—bone cancer	0.000223	0.00415	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—bone cancer	0.000218	0.00406	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—bone cancer	0.000217	0.00404	CcSEcCtD
Dinoprostone—Chills—Methotrexate—bone cancer	0.000215	0.00401	CcSEcCtD
Dinoprostone—Diarrhoea—Cisplatin—bone cancer	0.000213	0.00396	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—bone cancer	0.000209	0.00388	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—bone cancer	0.000206	0.00384	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—bone cancer	0.000204	0.0038	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—bone cancer	0.000203	0.00378	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—bone cancer	0.000202	0.00376	CcSEcCtD
Dinoprostone—Chills—Epirubicin—bone cancer	0.000202	0.00375	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—bone cancer	0.000201	0.00374	CcSEcCtD
Dinoprostone—Vomiting—Cisplatin—bone cancer	0.000198	0.00368	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—bone cancer	0.000197	0.00367	CcSEcCtD
Dinoprostone—Rash—Cisplatin—bone cancer	0.000196	0.00365	CcSEcCtD
Dinoprostone—Dermatitis—Cisplatin—bone cancer	0.000196	0.00365	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—bone cancer	0.000193	0.00359	CcSEcCtD
Dinoprostone—Tension—Epirubicin—bone cancer	0.000192	0.00357	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—bone cancer	0.000189	0.00352	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—bone cancer	0.000189	0.00351	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—bone cancer	0.000188	0.0035	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—bone cancer	0.000188	0.0035	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—bone cancer	0.000187	0.00347	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—bone cancer	0.000186	0.00346	CcSEcCtD
Dinoprostone—Nausea—Cisplatin—bone cancer	0.000185	0.00344	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—bone cancer	0.000184	0.00343	CcSEcCtD
Dinoprostone—Cough—Methotrexate—bone cancer	0.000182	0.0034	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—bone cancer	0.000178	0.00331	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—bone cancer	0.000178	0.00331	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—bone cancer	0.000178	0.00331	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—bone cancer	0.000178	0.00331	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—bone cancer	0.000175	0.00327	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—bone cancer	0.000175	0.00326	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—bone cancer	0.000174	0.00324	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—bone cancer	0.000172	0.0032	CcSEcCtD
Dinoprostone—Cough—Epirubicin—bone cancer	0.000171	0.00318	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—bone cancer	0.000171	0.00318	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—bone cancer	0.000171	0.00318	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—bone cancer	0.000169	0.00314	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—bone cancer	0.000167	0.0031	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—bone cancer	0.000167	0.0031	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—bone cancer	0.000167	0.0031	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—bone cancer	0.000165	0.00307	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—bone cancer	0.000162	0.00302	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—bone cancer	0.00016	0.00297	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—bone cancer	0.000159	0.00297	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—bone cancer	0.000159	0.00296	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—bone cancer	0.000158	0.00294	CcSEcCtD
Dinoprostone—Shock—Epirubicin—bone cancer	0.000157	0.00292	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—bone cancer	0.000156	0.00291	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—bone cancer	0.000156	0.0029	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000155	0.00289	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—bone cancer	0.000154	0.00287	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—bone cancer	0.000154	0.00287	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—bone cancer	0.000154	0.00287	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—bone cancer	0.000154	0.00287	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—bone cancer	0.000153	0.00285	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—bone cancer	0.000152	0.00283	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—bone cancer	0.000149	0.00278	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—bone cancer	0.000148	0.00275	CcSEcCtD
Dinoprostone—Pain—Methotrexate—bone cancer	0.000146	0.00272	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000145	0.00271	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—bone cancer	0.000145	0.00271	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—bone cancer	0.000144	0.00268	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—bone cancer	0.000143	0.00267	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—bone cancer	0.000143	0.00266	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—bone cancer	0.000142	0.00265	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—bone cancer	0.000139	0.0026	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—bone cancer	0.000138	0.00257	CcSEcCtD
Dinoprostone—Pain—Epirubicin—bone cancer	0.000137	0.00254	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—bone cancer	0.000135	0.00251	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—bone cancer	0.000135	0.00251	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000135	0.00251	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—bone cancer	0.000133	0.00247	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—bone cancer	0.000132	0.00245	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—bone cancer	0.000131	0.00243	CcSEcCtD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00013	0.000927	CbGpPWpGaD
Dinoprostone—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000127	0.000907	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—GNA11—bone cancer	0.000127	0.000905	CbGpPWpGaD
Dinoprostone—Pain—Doxorubicin—bone cancer	0.000126	0.00235	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—bone cancer	0.000126	0.00235	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—bone cancer	0.000126	0.00235	CcSEcCtD
Dinoprostone—PTGER3—Signaling by GPCR—SMO—bone cancer	0.000126	0.000898	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000126	0.000896	CbGpPWpGaD
Dinoprostone—Hypersensitivity—Methotrexate—bone cancer	0.000126	0.00234	CcSEcCtD
Dinoprostone—PTGER2—Signaling by GPCR—GNA11—bone cancer	0.000125	0.00089	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—IL3—bone cancer	0.000125	0.000889	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000125	0.000888	CbGpPWpGaD
Dinoprostone—Asthenia—Methotrexate—bone cancer	0.000122	0.00228	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—RGS1—bone cancer	0.000122	0.000869	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GRM4—bone cancer	0.000122	0.000869	CbGpPWpGaD
Dinoprostone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000121	0.00225	CcSEcCtD
Dinoprostone—CYP11A1—Metabolism—NT5C3A—bone cancer	0.000118	0.000843	CbGpPWpGaD
Dinoprostone—Hypersensitivity—Epirubicin—bone cancer	0.000118	0.00219	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—bone cancer	0.000117	0.00217	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—bone cancer	0.000117	0.00217	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—bone cancer	0.000117	0.00217	CcSEcCtD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000116	0.000823	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—GNA11—bone cancer	0.000115	0.000822	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—IL3—bone cancer	0.000115	0.00082	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GRM1—bone cancer	0.000115	0.000816	CbGpPWpGaD
Dinoprostone—Asthenia—Epirubicin—bone cancer	0.000115	0.00213	CcSEcCtD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000114	0.000815	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—ENO2—bone cancer	0.000114	0.000814	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL3—bone cancer	0.000113	0.000807	CbGpPWpGaD
Dinoprostone—Dizziness—Methotrexate—bone cancer	0.000113	0.0021	CcSEcCtD
Dinoprostone—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000112	0.0008	CbGpPWpGaD
Dinoprostone—Diarrhoea—Epirubicin—bone cancer	0.000109	0.00203	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—bone cancer	0.000109	0.00203	CcSEcCtD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000109	0.000773	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000109	0.000773	CbGpPWpGaD
Dinoprostone—Vomiting—Methotrexate—bone cancer	0.000108	0.00202	CcSEcCtD
Dinoprostone—Rash—Methotrexate—bone cancer	0.000108	0.002	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—bone cancer	0.000107	0.002	CcSEcCtD
Dinoprostone—Headache—Methotrexate—bone cancer	0.000107	0.00199	CcSEcCtD
Dinoprostone—HPGDS—Metabolism—DHFR—bone cancer	0.000106	0.000755	CbGpPWpGaD
Dinoprostone—Asthenia—Doxorubicin—bone cancer	0.000106	0.00197	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—GRM1—bone cancer	0.000106	0.000753	CbGpPWpGaD
Dinoprostone—Dizziness—Epirubicin—bone cancer	0.000106	0.00197	CcSEcCtD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000105	0.000747	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000105	0.000745	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL3—bone cancer	0.000105	0.000745	CbGpPWpGaD
Dinoprostone—Vomiting—Epirubicin—bone cancer	0.000101	0.00189	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—bone cancer	0.000101	0.00189	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—bone cancer	0.000101	0.00188	CcSEcCtD
Dinoprostone—Rash—Epirubicin—bone cancer	0.000101	0.00187	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—bone cancer	0.000101	0.00187	CcSEcCtD
Dinoprostone—Headache—Epirubicin—bone cancer	0.0001	0.00186	CcSEcCtD
Dinoprostone—HPGDS—Metabolism—GNA11—bone cancer	9.91e-05	0.000706	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.88e-05	0.000704	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SMO—bone cancer	9.83e-05	0.0007	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.77e-05	0.000696	CbGpPWpGaD
Dinoprostone—Dizziness—Doxorubicin—bone cancer	9.77e-05	0.00182	CcSEcCtD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	9.6e-05	0.000684	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SPARC—bone cancer	9.59e-05	0.000683	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—GNA11—bone cancer	9.5e-05	0.000677	CbGpPWpGaD
Dinoprostone—Nausea—Epirubicin—bone cancer	9.48e-05	0.00177	CcSEcCtD
Dinoprostone—CYP19A1—Metabolism—NDUFA12—bone cancer	9.46e-05	0.000674	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	9.44e-05	0.000672	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—SMO—bone cancer	9.43e-05	0.000672	CbGpPWpGaD
Dinoprostone—Vomiting—Doxorubicin—bone cancer	9.39e-05	0.00175	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—bone cancer	9.31e-05	0.00173	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—bone cancer	9.3e-05	0.00173	CcSEcCtD
Dinoprostone—PTGIR—GPCR downstream signaling—GNA11—bone cancer	9.3e-05	0.000662	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—GNA11—bone cancer	9.3e-05	0.000662	CbGpPWpGaD
Dinoprostone—Headache—Doxorubicin—bone cancer	9.25e-05	0.00172	CcSEcCtD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.24e-05	0.000658	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—SMO—bone cancer	9.23e-05	0.000658	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—SMO—bone cancer	9.23e-05	0.000658	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GRM4—bone cancer	9.12e-05	0.00065	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RGS1—bone cancer	9.12e-05	0.00065	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.05e-05	0.000645	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—GNA11—bone cancer	8.99e-05	0.00064	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—CYP3A4—bone cancer	8.98e-05	0.00064	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NDUFA12—bone cancer	8.95e-05	0.000637	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.94e-05	0.000637	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RGS1—bone cancer	8.93e-05	0.000636	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RGS1—bone cancer	8.93e-05	0.000636	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GRM4—bone cancer	8.93e-05	0.000636	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GRM4—bone cancer	8.93e-05	0.000636	CbGpPWpGaD
Dinoprostone—Nausea—Doxorubicin—bone cancer	8.77e-05	0.00163	CcSEcCtD
Dinoprostone—ABCC4—Hemostasis—GNA11—bone cancer	8.77e-05	0.000625	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—PLAU—bone cancer	8.75e-05	0.000623	CbGpPWpGaD
Dinoprostone—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.72e-05	0.000621	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NT5C3A—bone cancer	8.67e-05	0.000618	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—GNA11—bone cancer	8.63e-05	0.000614	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—IL3—bone cancer	8.61e-05	0.000613	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	8.49e-05	0.000605	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—GNA11—bone cancer	8.44e-05	0.000601	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—GNA11—bone cancer	8.44e-05	0.000601	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.44e-05	0.000601	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—IL3—bone cancer	8.43e-05	0.0006	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—IL3—bone cancer	8.43e-05	0.0006	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ATF1—bone cancer	8.36e-05	0.000595	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	8.31e-05	0.000592	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NDUFA12—bone cancer	8.2e-05	0.000584	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL3—bone cancer	8.15e-05	0.000581	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SMO—bone cancer	8.07e-05	0.000575	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	8.05e-05	0.000573	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IL3—bone cancer	7.95e-05	0.000566	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GRM1—bone cancer	7.91e-05	0.000563	CbGpPWpGaD
Dinoprostone—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.88e-05	0.000561	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NT5C3A—bone cancer	7.84e-05	0.000558	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL3—bone cancer	7.82e-05	0.000557	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GRM1—bone cancer	7.74e-05	0.000551	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GRM1—bone cancer	7.74e-05	0.000551	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GSTP1—bone cancer	7.68e-05	0.000547	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL3—bone cancer	7.65e-05	0.000545	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL3—bone cancer	7.65e-05	0.000545	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NDUFA12—bone cancer	7.64e-05	0.000544	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.59e-05	0.000541	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SMO—bone cancer	7.45e-05	0.000531	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NT5C3A—bone cancer	7.41e-05	0.000528	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GNA11—bone cancer	7.38e-05	0.000526	CbGpPWpGaD
Dinoprostone—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.1e-05	0.000506	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ENO2—bone cancer	7.06e-05	0.000503	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	6.99e-05	0.000498	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFBR2—bone cancer	6.97e-05	0.000497	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ATF1—bone cancer	6.86e-05	0.000489	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.85e-05	0.000488	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GNA11—bone cancer	6.81e-05	0.000485	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NT5C3A—bone cancer	6.79e-05	0.000484	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL3—bone cancer	6.69e-05	0.000477	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	6.65e-05	0.000474	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IGF1R—bone cancer	6.56e-05	0.000467	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—DHFR—bone cancer	6.55e-05	0.000467	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ATF1—bone cancer	6.33e-05	0.000451	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NT5C3A—bone cancer	6.33e-05	0.000451	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	6.2e-05	0.000442	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL3—bone cancer	6.18e-05	0.00044	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.97e-05	0.000425	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ENO2—bone cancer	5.92e-05	0.000421	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.88e-05	0.000419	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFBR2—bone cancer	5.73e-05	0.000408	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	5.57e-05	0.000397	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMO—bone cancer	5.57e-05	0.000397	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	5.5e-05	0.000392	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—DHFR—bone cancer	5.49e-05	0.000391	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMO—bone cancer	5.45e-05	0.000388	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMO—bone cancer	5.45e-05	0.000388	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1R—bone cancer	5.39e-05	0.000384	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.38e-05	0.000383	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.38e-05	0.000383	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFBR2—bone cancer	5.28e-05	0.000376	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PLAU—bone cancer	5.21e-05	0.000371	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	5.19e-05	0.00037	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ENO2—bone cancer	5.18e-05	0.000369	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNA11—bone cancer	5.13e-05	0.000365	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.1e-05	0.000363	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—BRAF—bone cancer	5.1e-05	0.000363	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNA11—bone cancer	5.1e-05	0.000363	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.03e-05	0.000358	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNA11—bone cancer	4.99e-05	0.000355	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNA11—bone cancer	4.99e-05	0.000355	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1R—bone cancer	4.97e-05	0.000354	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—DHFR—bone cancer	4.81e-05	0.000342	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KIT—bone cancer	4.76e-05	0.000339	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—BRAF—bone cancer	4.75e-05	0.000338	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFBR2—bone cancer	4.75e-05	0.000338	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ATF1—bone cancer	4.74e-05	0.000337	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CYP3A4—bone cancer	4.65e-05	0.000331	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ATF1—bone cancer	4.64e-05	0.00033	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ATF1—bone cancer	4.64e-05	0.00033	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL3—bone cancer	4.62e-05	0.000329	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	4.62e-05	0.000329	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL3—bone cancer	4.52e-05	0.000322	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL3—bone cancer	4.52e-05	0.000322	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNA11—bone cancer	4.49e-05	0.00032	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—BRAF—bone cancer	4.47e-05	0.000318	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—EGFR—bone cancer	4.33e-05	0.000309	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—MDM2—bone cancer	4.27e-05	0.000304	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP3A4—bone cancer	4.07e-05	0.00029	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.05e-05	0.000289	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGS2—bone cancer	3.98e-05	0.000283	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—MDM2—bone cancer	3.98e-05	0.000283	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSTP1—bone cancer	3.98e-05	0.000283	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFBR2—bone cancer	3.95e-05	0.000281	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KIT—bone cancer	3.91e-05	0.000278	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFBR2—bone cancer	3.87e-05	0.000275	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFBR2—bone cancer	3.87e-05	0.000275	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ENO2—bone cancer	3.8e-05	0.00027	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MDM2—bone cancer	3.75e-05	0.000267	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1R—bone cancer	3.72e-05	0.000265	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—BRAF—bone cancer	3.67e-05	0.000262	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1R—bone cancer	3.64e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1R—bone cancer	3.64e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KIT—bone cancer	3.61e-05	0.000257	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NDUFA12—bone cancer	3.58e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—EGFR—bone cancer	3.56e-05	0.000254	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—DHFR—bone cancer	3.52e-05	0.000251	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—bone cancer	3.52e-05	0.000251	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTP1—bone cancer	3.48e-05	0.000248	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ENO2—bone cancer	3.43e-05	0.000244	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—BRAF—bone cancer	3.39e-05	0.000241	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNA11—bone cancer	3.29e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—bone cancer	3.28e-05	0.000234	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—JUN—bone cancer	3.26e-05	0.000232	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO2—bone cancer	3.25e-05	0.000231	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KIT—bone cancer	3.24e-05	0.000231	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—DHFR—bone cancer	3.18e-05	0.000227	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—bone cancer	3.17e-05	0.000226	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MDM2—bone cancer	3.08e-05	0.000219	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—BRAF—bone cancer	3.05e-05	0.000217	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—DHFR—bone cancer	3.01e-05	0.000215	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.99e-05	0.000213	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO2—bone cancer	2.98e-05	0.000212	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNA11—bone cancer	2.98e-05	0.000212	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.97e-05	0.000212	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NT5C3A—bone cancer	2.96e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MDM2—bone cancer	2.84e-05	0.000202	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNA11—bone cancer	2.82e-05	0.000201	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO2—bone cancer	2.77e-05	0.000198	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—DHFR—bone cancer	2.76e-05	0.000197	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP3A4—bone cancer	2.7e-05	0.000192	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KIT—bone cancer	2.7e-05	0.000192	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.68e-05	0.000191	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—JUN—bone cancer	2.67e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KIT—bone cancer	2.64e-05	0.000188	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KIT—bone cancer	2.64e-05	0.000188	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—bone cancer	2.6e-05	0.000185	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNA11—bone cancer	2.58e-05	0.000184	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—DHFR—bone cancer	2.57e-05	0.000183	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—bone cancer	2.56e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTP1—bone cancer	2.55e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.55e-05	0.000182	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MDM2—bone cancer	2.55e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.54e-05	0.000181	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—BRAF—bone cancer	2.53e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—BRAF—bone cancer	2.48e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—BRAF—bone cancer	2.48e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—JUN—bone cancer	2.47e-05	0.000176	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—bone cancer	2.46e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—bone cancer	2.46e-05	0.000175	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNA11—bone cancer	2.4e-05	0.000171	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—bone cancer	2.4e-05	0.000171	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—bone cancer	2.4e-05	0.000171	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—bone cancer	2.4e-05	0.000171	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP3A4—bone cancer	2.34e-05	0.000167	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTP1—bone cancer	2.31e-05	0.000164	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTP1—bone cancer	2.18e-05	0.000156	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP3A4—bone cancer	2.18e-05	0.000155	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—bone cancer	2.15e-05	0.000153	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MDM2—bone cancer	2.12e-05	0.000151	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—bone cancer	2.1e-05	0.00015	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—bone cancer	2.1e-05	0.000149	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MDM2—bone cancer	2.08e-05	0.000148	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MDM2—bone cancer	2.08e-05	0.000148	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—bone cancer	2.06e-05	0.000147	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—bone cancer	2e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—bone cancer	1.94e-05	0.000138	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—bone cancer	1.86e-05	0.000133	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—bone cancer	1.85e-05	0.000131	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—bone cancer	1.81e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—bone cancer	1.81e-05	0.000129	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—bone cancer	1.8e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—bone cancer	1.8e-05	0.000128	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—bone cancer	1.77e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—bone cancer	1.76e-05	0.000125	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—bone cancer	1.76e-05	0.000125	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—bone cancer	1.74e-05	0.000124	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—bone cancer	1.63e-05	0.000116	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—bone cancer	1.45e-05	0.000103	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—bone cancer	1.42e-05	0.000101	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—bone cancer	1.42e-05	0.000101	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—bone cancer	1.32e-05	9.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO2—bone cancer	1.3e-05	9.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—bone cancer	1.22e-05	8.68e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DHFR—bone cancer	1.2e-05	8.58e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—bone cancer	1.2e-05	8.51e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—bone cancer	1.19e-05	8.49e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—bone cancer	1.19e-05	8.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—bone cancer	1.13e-05	8.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNA11—bone cancer	1.13e-05	8.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—bone cancer	1.04e-05	7.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP3A4—bone cancer	1.02e-05	7.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.02e-05	7.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—bone cancer	9.66e-06	6.88e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—bone cancer	8.73e-06	6.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—bone cancer	4.52e-06	3.22e-05	CbGpPWpGaD
